2012
DOI: 10.1016/j.ejps.2012.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Viability of freeze dried microencapsulated human retinal pigment epithelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
1

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 35 publications
0
7
1
Order By: Relevance
“…36% using the optimal conditions is not within the acceptable range for reproducibility and scaleup from laboratory R&D to commercial scale processes. Moreover, the reported yields in this study are significantly lower than those reported across various mammalian cell lines in the literature (Eroglu et al 2000, He 2011, Lee et al 2013, Limaye and Kale 2001, Mart ın-Ib añez et al 2012, Serra et al 2011, Wikstr€ om et al 2012, Zhang et al 2010) specifically, 60% post-thawing efficiency has been reported for HEK cells using 5% DMSO dissolved in histidine-tryptophan-ketoglutarate medium (Chaytor et al 2012), which is at least 70% higher than the values obtained for the optimal conditions in 2D using DMSO (Run 8). The latter can be explained by higher viability efficiencies immediately after thawing relative to those observed after 1-7 days culture of the thawed cells (Heng et al 2006).…”
Section: Comparison With Other Cryoprotectantscontrasting
confidence: 72%
See 1 more Smart Citation
“…36% using the optimal conditions is not within the acceptable range for reproducibility and scaleup from laboratory R&D to commercial scale processes. Moreover, the reported yields in this study are significantly lower than those reported across various mammalian cell lines in the literature (Eroglu et al 2000, He 2011, Lee et al 2013, Limaye and Kale 2001, Mart ın-Ib añez et al 2012, Serra et al 2011, Wikstr€ om et al 2012, Zhang et al 2010) specifically, 60% post-thawing efficiency has been reported for HEK cells using 5% DMSO dissolved in histidine-tryptophan-ketoglutarate medium (Chaytor et al 2012), which is at least 70% higher than the values obtained for the optimal conditions in 2D using DMSO (Run 8). The latter can be explained by higher viability efficiencies immediately after thawing relative to those observed after 1-7 days culture of the thawed cells (Heng et al 2006).…”
Section: Comparison With Other Cryoprotectantscontrasting
confidence: 72%
“…In the quiescent state, cells enter an amorphous/glassy phase characterized by low molecular mobility and activity to arrest biophysical and biochemical cellular activities. Successful preservation is governed by complex interactions between the type and concentration of cryo/lyoprotectant cocktails, kinetics of liquid water removal enhanced by 3D conformation, as well as cell-cell and cell-matrix interactions and specific properties of the individual IC cell lines (He 2011, Mart ın-Ib añez et al 2012, Serra et al 2011, Wikstr€ om et al 2012, Zhang et al 2010. The critical variables leading to cryo-injury, use of cryoprotective agents (CPAs) and biophysics of mammalian cell cryopreservation for optimal recovery rates based on modeling of cell dehydration and intracellular ice formation have been extensively reviewed by He (2011) and Mart ın-Ib añez et al (2012).…”
Section: Introductionmentioning
confidence: 99%
“…To achieve higher concentration of intracellular trehalose, other loading methods such as freezing induced loading [59] or acetylation of trehalose [1] could be implemented. In addition, by extending the loading time for trehalose, the amount of intracellular trehalose increases [56]. However, HepG2 cell spheroids share less total surface area with surrounding media which might reduce the efficacy of given methods.…”
Section: Discussionmentioning
confidence: 99%
“…In anhydrobiotic organisms the amount of trehalose is typically high [9]. In addition, intracellular trehalose appears to protect DNA integrity, mononuclear cells and retinal pigment epithelial cells [40,56,60]. It has been also reported that in addition to trehalose other excipients are required to dry mammalian cells [38,49].…”
Section: Introductionmentioning
confidence: 99%
“…At present, cell microencapsulation technology is considered to be a viable therapy. Microencapsulated somatic cells can be used to treat neurological and endocrine diseases, such as diabetes, syndromes after the removal of ovaries, and Parkinson's disease . Microencapsulated stem cells can aid bone regeneration and growth plate injury, repair the myocardium and improve angiogenesis .…”
Section: Introductionmentioning
confidence: 99%